The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora, and its AI-powered deep learning image reconstruction technology, Clarify DL.
Aurora features a 40 mm detector and 128-slice imaging capabilities to support clinical applications from cardiology to oncology and neurology, the company said. It also includes 5/8-inch crystal NaI detectors.
Clarify DL enhances bone SPECT image quality performance, according to GEHC.
